# Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection

> **NCT04325633** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 30 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** 1: Naproxen
- **DRUG:** 2: Standard of care

## Key facts

- **NCT ID:** NCT04325633
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-24
- **Primary completion:** 2020-12-15
- **Final completion:** 2020-12-15
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Stop inclusions for insufficient recruitment
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04325633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04325633, "Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04325633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*